myGenome is a comprehensive genetic test to assess health outcomes, analyzing 566 genes linked to over 650 conditions, and identifying carrier status for more than 200 inherited disorders. We explore the impact of genes and environment on complex diseases and traits, study genetic responses to over 250 medications, and trace ancestry to uncover your genetic origins. Our tests empower you with valuable insights to make informed decisions about your health and well-being, helping you take control of your future.

myHealthScore is designed for adults who are proactive about their health, offering insights into lifetime risks for diseases to guide preventive strategies and lifestyle changes. myHealthScore evaluates conditions like cardiovascular disease, type 2 diabetes, and cancer. It reclassifies cardiovascular risk levels, identifies genetic predispositions to type 2 diabetes, detects polygenic breast cancer risks often missed by other tests, and improves prostate cancer screening. This personalized approach empowers patients and healthcare providers to make informed, proactive decisions.

myPrenatal detects common chromosomal abnormalities like Down, Edwards, and Patau syndromes (trisomies 21, 18, and 13), as well as sex chromosome alterations. It is suitable from the 10th week of gestation for singleton and twin pregnancies, including those achieved through assisted reproductive techniques, using only the mother's blood sample.

myGeneticRisk is a preventive genetic test that assesses the hereditary risk of heart disease and cancer, two of the most common global diseases. Understanding your predisposition allows specialists to implement strategies for early detection and prevention, when treatments are more effective. The test analyzes 162 genes linked to clinically relevant, actionable diseases, including key genes for cardiovascular disease and cancer, and also includes other conditions recommended by the ACMG (American College of Medical Genetics and Genomics).

myCancerRisk is a genetic test that assesses the risk of hereditary cancer through the analysis of 40 genes linked to common hereditary cancers. It is suitable for individuals diagnosed with cancer, those with close relatives who had cancer before age 50, people with a family history suggesting a hereditary cancer risk, and anyone interested in understanding their hereditary cancer risk.

myCardio genetic test is used in diagnosing inherited cardiovascular conditions using whole exome sequencing and the analysis of 100 genes selected by cardiovascular genetics experts. It is ideal for individuals with suspected or diagnosed cardiovascular issues, those who have a family history of heart disease, and people, especially athletes, who want to assess their risk of cardiovascular disease.